STEP-HFpEF Program Echocardiography Substudy

Back

ESC Professional Premium Access

STEP-HFpEF Program Echocardiography Substudy

Session: Clinical trial updates on the GLP-1 receptor agonist, semaglutide

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Professor S. Solomon (Boston, US)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Professor Scott Solomon

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

73 presentations

28 followers

7 more presentations in this session

Atrial fibrillation and efficacy of semaglutide 2.4 mg in obesity-related HFpEF: A Patient Level Pooled analysis of STEP-HFpEF and STEP-HFpEF DM trials

Speaker: Doctor M. Kosiborod (Kansas City, US)

Access

Slides

Video

Inflammation in obesity-related HFpEF: the STEP-HFpEF programme

Speaker: Professor S. Verma (Toronto, CA)

Access

Slides

Video

Effects of the GLP-1 receptor agonist, semaglutide, on heart failure outcomes: a pre-specified analysis of the FLOW trial in participants with type 2 diabetes and chronic kidney disease

Speaker: Doctor R. Pratley (Orlando, US)

Access

Slides

Video

Effects of semaglutide on clinical events in heart failure with preserved ejection fraction: a pooled, participant-level analysis of SELECT, FLOW, STEP-HFpEF and STEP-HFpEF DM trials

Speaker: Doctor M. Kosiborod (Kansas City, US)

Access

Slides

Video

Semaglutide and cardiovascular outcomes in females with overweight and obesity: A prespecified analysis of the SELECT trial

Speaker: Professor S. Verma (Toronto, CA)

Access

Slides

Video

Access the full session

Clinical trial updates on the GLP-1 receptor agonist, semaglutide

Speakers: Professor S. Solomon, Doctor M. Kosiborod, Professor S. Verma, Doctor R. Pratley, Doctor M. Kosiborod...

Access

Video

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources